NCT07124559: A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 144 planned
- Started
- 28 Sep 2026
- Primary completion
- 26 Jun 2028
- Arms
- Cohort 2: Children living with HIV
- Results
- None posted
- 15 Aug 2025: Trial registered
- 28 Sep 2026: Trial started